Ribavirin

Trade Name: Daklinza Generic Name: Daclatasvir Daklinza is a newly the Food and Drugs Administration (FDA) approved drug to treat patients with chronic hepatitis C genotype 3 infection.4 The company that markets the drug is Bristol-Myers Squibb, located in Princeton, New Jersey. The date of approval by the U.S FDA for the drug is July 24th, 2015. Although, Japan was the first country in the world to approve the drug , now the drug is being marketed in U.S, including northern and central…

During the last decade the HIV disease was the number one growing problem for many Americans. As of 2016, Hepatitis C (HCV) receives the attention as the new infectious disease in the United States and countries around the world. Hepatitis C has become a persistent developing virus that can cause serious liver infection if not treated. The Virus was identified in 1989, as non-A non-B hepatitis. It is refer to as the “Silent Epidemic”. For years HCV blood borne disease has infected individuals…